Psych Meds Flashcards
TCAs MOA:
Increase Norepinephrine
-Tx for Depression/Anxiety, relieve Chronic Pain
SSRIs MOA:
Increase Serotonin
-Tx for Depression, Anxiety Disorders (Panic DO, GAD, Social Anxiety DO, PTSD) - 1st line, OCD
MAOIs MOA:
- FILL IN
- Not used much b/c cause hypertensive crisis with tyramine exposure
Nefazodone (Serzone)
- Increase Serotonin BOTH pre- and post-synaptically
- Tx for Depression and ???
Venlafaxine (Effexor)
- Mixed Serotonin/Norepinephrine agent
- Tx for Depression and ???
Buproprion (Wellbutrin)
-Acts on Dopamine receptors
Chlorpromazine (Thorazine)
Antipsychotic that blocks dopamine receptors
Thioridazine (Mellaril)
Antipsychotic that blocks dopamine receptors
Haloperidol (Haldol)
Antipsychotic that blocks dopamine receptors
Clozapine (Clozaril)
Atypical antipsychotic
1. Tx: Tx-resistant schizophrenia & schizoaffective DO (pt who failed 2+ antipsychotics)
- SEs:
- Leukopenia (Neutropenia) - Agranulocytosis
* *Must monitor WBCs & Abs Neutrophil Ct
- Eosinophilia is possible
- Wt gain, metabolic syndrome, seizures, ileus, myocarditis, hypotension
- LEAST LIKELY to cause EPS
- DOES NOT CAUSE tardive dyskinesia
Risperidone (Risperdal)
Atypical antipsychotic
Olanzapine (Zyprexa)
Antypical antipsychotic
Benzodiazepines
Sedative hypnotics
- Affect GABA neurotransmitter system & relieve anxiety
- SEs: Sedation, reduced reflexes, tolerance, potential for addiction
Atypical antipsychotics with risk of orthostatic hypotension:
HIGH RISK:
- Quetiapine
- Clozapine
- Respiridone
LOW RISK:
- Aripiprazole
- Olanzapine
- Ziprasidone
Atypical antipsychotics with risk of metabolic syndrome:
HIGH RISK: Clozapine, Olanzapine
MEDIUM RISK: Quetiapine, Respiridone
LOW RISK: Aripiprazole, Ziprasidone
Atypical antispychotics with risk of anticholinergic side effects:
HIGH RISK:
- Clozapine
- Olanzapine
- Quetiapine
LOW RISK:
- Aripiprazole
- Respiridone
- Ziprasadone
Short-acting injectible atypical antipsychotics:
- Olanzipine
2. Ziprasidone
Long-acting/Depot form injectible atypical antipsychotics:
- Aripiprazole (dangerous) (Abilify mantenna)
- Olanzapine
- Respiridone (Resperdal consta) or Paliperidone (Invega sustenna)
Lithium indications:
- Tx for acute mania and maintenance therapy in Bipolar Disorder
- Has narrow therapeutic index, so can cause toxicity easily –> monitor drug levels every 6-12 months and 5-7 days after dose change or starting other meds that could interact.
Lithium side effects:
Acute:
- Tremor, ataxia, weakness
- Polyuria, polydipsia
- Vomiting, diarrhea
- Cognitive impairment
- Wt gain
Chronic:
- Nephrogrenic diabetes insipidus
- Thyroid dysfunction
- Hyperparathyroidism w/hypercalcemia
Pregnancy:
- Exposure in 1st trimester causes cardiac malformations (septal defects & Ebstein’s anomoly –> atrialization of rt ventricle)
- Exposure in 2nd/3rd trimesters causes goiter and transient neonatal neuromuscular dysfunction.
Lithium contraindications:
Don’t use lithium in pts with:
- Heart disease (HD)
- Chronic kidney disease (CKD)
- Hyponatremia or Diuretic use
- Pregnancy - Litihium should be avoided or dose adjusted b/c it can cause complications in 1st trimester (Ebstein’s anomoly) and later stages (Polyhydramnios, DI, Floppy Baby)
Baseline studies required before Lithium use:
- BUN, Cr, Calcium, Urinalysis
- Thyroid Fxtn Tests
- ECG in pts w/coronary/CAD risk factors (HTN, DM, smoking)